These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4299754)

  • 1. Oncogenesis and poliomyelitis vaccine.
    Innis MD
    Nature; 1968 Aug; 219(5157):972-3. PubMed ID: 4299754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination in childhood].
    Spiess H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):125-31. PubMed ID: 4550326
    [No Abstract]   [Full Text] [Related]  

  • 3. Keeping immunizations up to date.
    Reece RM
    Am Fam Physician; 1974 Mar; 9(3):119-25. PubMed ID: 4855929
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccination statistics for the year 1964 (D.T. and associated D.T. vaccines: D.T.T.A.B.: D.T. polio; D.T.C.; D.T.C. polio)].
    Chassagne P; Devaux JP
    Bull Inst Natl Sante Rech Med; 1966; 21(4):663-71. PubMed ID: 5974691
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current problems of vaccination].
    Grahneis H
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):510-6. PubMed ID: 4398882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Norms o vaccination in the republic of Ecuador].
    Aroca Campodónico F; Baldeón Barros WG
    Rev Ecuat Hig Med Trop; 1969; 26(2):141-63. PubMed ID: 5400615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systematization of reactions developing after prophylactic vaccination].
    Nosov SD; Braginskaia VP
    Pediatriia; 1972 Feb; 51(2):10-5. PubMed ID: 5036291
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple antigen vaccine strategies in developing countries.
    Foege WH; Foster SO
    Am J Trop Med Hyg; 1974 Jul; 23(4):685-9. PubMed ID: 4847043
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dermatologic counterindications for protective vaccination in the GDR].
    Dietz O
    Z Arztl Fortbild (Jena); 1971 Aug; 65(15):803-6. PubMed ID: 4259138
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization practice in the United Sttes and Great Britain: a comparative study.
    Karzon DT
    Postgrad Med J; 1969 Feb; 45(520):147-60. PubMed ID: 4891575
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to vaccination statistics in childhood].
    Hayek H
    Wien Med Wochenschr; 1968 May; 118(20):462-4. PubMed ID: 5702496
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine active immunisations in paediatric practice.
    Jain AM
    J Indian Med Assoc; 1968 Nov; 51(9):452-6. PubMed ID: 5729064
    [No Abstract]   [Full Text] [Related]  

  • 14. [New data on the possibilities of immunizing infants during their first years].
    Mande R; Fillastre C; Ajjan N; Orssaud E
    Arch Fr Pediatr; 1969 Feb; 26(2):155-77. PubMed ID: 5375874
    [No Abstract]   [Full Text] [Related]  

  • 15. Current status of vaccine-preventable diseases.
    Witte JJ
    Postgrad Med; 1974 Oct; 56(4):55-9. PubMed ID: 4412686
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
    Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
    Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunization program for domiciliaries (chronic disease facilities).
    Fisher S
    J Am Geriatr Soc; 1969 Oct; 17(10):938-49. PubMed ID: 5343853
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current status of combined vaccines.
    Brown GC
    Health Lab Sci; 1971 Oct; 8(4):210-4. PubMed ID: 4940069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.